QMoat Research
Evidence-led company analysis for patient, long-term investors.
Latest research
Apple’s first foldable could strengthen its lucrative services business. At almost 40 times earnings, investors need evidence of incremental profits beyond a premium launch.
VeriSign’s registration surge strengthens its growth case. At roughly 32 times trailing earnings, investors still need those new domains to renew and sustain the franchise’s cash generation.
Subscription growth and retention are cushioning Netflix’s advertising setback. The investment case now rests on whether that breathing room produces better monetization—and whether reported earnings overstate the stock’s apparent cheapness.
Latest research
Stronger organic growth and margins support Thermo Fisher’s recovery. At roughly 27.5 times guided adjusted earnings, however, investors also need better returns on the capital committed to acquisitions.
Align Technology ended the year with a rare combination: record Invisalign shipments, improving profitability, and a steadier tone from management. The catch is familiar—average revenue per case is still drifting down as growth tilts toward lower-priced markets and heavier discounts, forcing the company to prove it can expand margins through productivity, not pricing power.
Zoetis shares plunged after a rare growth wobble in its pet-health franchise. But with margins intact and valuations reset, the selloff looks more like the end of a perfection trade than a structural break—raising the question: is this the moment to buy?
Latest research
Higher volumes are lifting P&G’s sales, but reinvestment and commodity costs are squeezing margins. At nearly 24 times guided core earnings, the recovery needs to deliver more profit.
Sephora and jewelry are supporting LVMH’s sales, but fashion and leather goods have slipped again. At roughly 18 times earnings, the investment case rests on the durability of that division’s profits.
International growth is strengthening PepsiCo’s earnings base, but North American margin pressure has forced an earnings reset. A modest valuation compensates investors for execution risk rather than eliminating it.
Latest research
Platinum customers kept spending after a steep fee increase. Amex must now turn that loyalty into stronger profits while containing benefits costs and cutting jobs without weakening service.
Travelers’ profitable underwriting franchise is intact, but reserve gains, investment income and buybacks drove much of the improvement. A valuation above twice adjusted book demands durable returns.
Record assets grab attention, but organic fees and operating leverage offer better evidence of BlackRock’s moat. Acquisition adjustments and volatile gains complicate the valuation of that growing franchise.
Latest research
Amazon’s potential equity reward gives 3M a route to larger optical sales. The investment test is whether customer access and manufacturing scale produce returns that justify the incentive.
A jump in utilities lifted September industrial production, while factory growth stayed modest. Rising input costs make margins and cash conversion the decisive tests for quality industrial investors.
Copart’s acquisition expands its dealer auction business, but ACV remains loss-making under GAAP. The test is whether shared buyers, infrastructure and data can justify the capital committed.
Latest research
Latest research
Most investors can name Buffett or Terry Smith. But a quieter elite of “quality purists” has been compounding capital far from the spotlight — from Montréal to Hong Kong, from Zurich to London. They buy great businesses, hold them for years, and let time do the heavy lifting.
After years of dominance, the quality factor has stumbled since mid-2024 as markets chased risk and valuations stretched. Narrow leadership and speculative fervor left steady earners behind—but shifting tides could soon restore quality’s quiet strength.
Normalize patents by population and the leaderboard flips. A small cadre of export-driven, research-heavy economies consistently turn lab work into defensible products—via tight lab-to-factory loops, patient capital, and standards savvy.
Latest research
China’s industrial profits rose 15.7%, but electronics supplied 62% of the gain while several expanding industries earned less. The quality test is who converts growth into cash.
For Marsh, Aon, WTW and Gallagher, AI looks less like a guillotine than a lever—stripping costs from placements, sharpening advisory clout, and spawning new insurable risks—even as it pressures small-ticket business. The winners weld data, governance and speed into advantage.
From IKEA to Spotify, Sweden keeps turning its modest size into a factory of world-class firms. The secret lies in long-term ownership, digital infrastructure, and a culture where ambition, trust, and design discipline quietly compound into global scale.
Latest research
September's weak U.S. hiring and slower wage growth may ease pressure on interest rates. For quality investors, the harder question is which companies can keep demand while costs cool.
Investors are trained to admire fast top lines. In buoyant markets, momentum plus a large total addressable market can mesmerize. But not all growth creates value.
Every market cycle produces stocks that look irresistibly cheap and then refuse to go anywhere. The “value trap” is the classic case: a low multiple that masks eroding economics, overstated assets or fragile balance sheets. Screening for single-digit P/Es or high dividend yields can be a useful starting point, but it is also how many investors get caught.
QMoat Research System
Compare companies across financial strength, durable competitive advantages and governance.
